Equitable Access to Rare Diseases Therapies

Recorded on 2/23/2022

Distinguished Speakers

Moderator: Mr. Joff Masukawa, President, Diligentia Strategy; Board of Directors, CHI

Panelist: Ms. Sara Aswegan, Rare Disease Global Medical Affairs Head-Managed Access and Communications, UCB

Panelist: Dr. Mauvareen Beverley, MD, Advisor, Westchester Sickle Cell Outreach; Patient Engagement and Cultural Competence Specialist

Panelist: Ms. Jennifer Bright, MPA, Executive Director, Innovation and Value Initiative (IVI)

Panelist: Mr. Dan Donovan, Founder & CEO, rareLife Solutions